Radiosensitivity Index Remains Stable Across Glioma Progression, Study Finds

A research group from Niigata University of Health and Welfare and Yamaguchi University discovered that the Radiosensitivity Index (RSI), which predicts the effectiveness of radiation therapy in glioma patients, tends not to change significantly even after recurrence. Analyzing data from 214 patients and 7,000 single cells, the study suggests that initial surgical data can provide valuable reference for personalized treatment when recurrent tumor sampling is difficult.